Orthopedic devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Spinal surgery includes devices used in the surgical treatment of degenerative disc diseases, intra-vertebral fractures and scoliosis. VCF Repair devices are a set of surgical devices used to perform minimally invasive surgical procedures in patients suffering from Vertebral Compression Fractures (VCF). GlobalData uses proprietary data and analytics to provide a comprehensive report on the vertebral compression fractures devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the vertebral compression fractures market in the US was Medtronic followed by Stryker, DePuy Synthes and Globus Medical.
The minimally invasive surgical procedures that utilize VCF Repair Devices are known as Vertebroplasty and Kyphoplasty procedures. Vertebroplasty is the injection of bone cement into the vertebral body to relieve pain or stabilize fractured vertebrae. Similar to vertebroplasty, kyphoplasty injects a bone cement into the vertebrae but with the additional step of creating space to enable use of a balloon-like device (balloon vertebroplasty). Kyphoplasty, also known as Balloon Kyphoplasty, involves inflation of a balloon to create a cavity for the bone cement in fractured and compressed bone. Vertebroplasty devices are used to perform Percutaneous Vertebroplasty procedures in patients who do not respond to conservative treatment and continue to suffer from severe pain as a result of Vertebral Compression Fractures.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the vertebral compression fractures devices market within the US was expected to be over $90m in 2022.
For the latest complete market share analysis of vertebral compression fractures device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
